These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 7002779)

  • 1. Mutagenic activity of chemicals previously tested for carcinogenicity in the National Cancer Institute bioassay program.
    Dunkel VC; Simmon VF
    IARC Sci Publ; 1980; (27):283-301. PubMed ID: 7002779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli.
    Dunkel VC; Zeiger E; Brusick D; McCoy E; McGregor D; Mortelmans K; Rosenkranz HS; Simmon VF
    Environ Mutagen; 1985; 7 Suppl 5():1-248. PubMed ID: 3905369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proportions of mutagens among chemicals in commerce.
    Zeiger E; Margolin BH
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds.
    Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O
    Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.
    Dorado G; Pueyo C
    Cancer Res; 1988 Feb; 48(4):907-12. PubMed ID: 3276401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative studies on the Salmonella/microsome mutagenicity assay.
    Dunkel VC
    J Assoc Off Anal Chem; 1979 Jul; 62(4):874-82. PubMed ID: 387710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
    Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
    Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
    White PA; Rasmussen JB
    Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays.
    Seifried HE; Seifried RM; Clarke JJ; Junghans TB; San RH
    Chem Res Toxicol; 2006 May; 19(5):627-44. PubMed ID: 16696565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rodent carcinogens by an expert system.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.